[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:muc16-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"MUC16 Gene",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07154290","A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced\u002FMetastatic Non-Small Cell Lung Cancer (NSCLC)",[11],"Phase 2","RECRUITING","2026-08-26T02:15:20.225313Z","2026-04-29T02:57:57.175480Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06469281","A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers",[19],"Phase 1","2026-08-26T02:17:10.213717Z","2026-05-05T02:43:29.649784Z"]